Synthetic Biosensors Market (By Type: Sensor Patch, Embedded Device; By Product: Wearable Synthetic biosensors, Non-wearable Synthetic biosensors; By Technology: Electrochemical Synthetic biosensors, Optical Synthetic biosensors, Piezoelectric Synthetic biosensors, Thermal Synthetic biosensors, Nanomechanical Synthetic biosensors; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030
The global synthetic biosensors market size was exhibited at USD 25.8 billion in 2022 and is expected to hit around USD 47.6 billion by 2030 with a CAGR of 7.96% during the forecast period 2022 to 2030.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The global synthetic biosensors market is anticipated to witness potential growth opportunities due to an increase in applications in various industries such as pharmaceutical, healthcare, food, agriculture, environment, and others. The increase in government investment in the health and pharmaceutical industries, the incidence of cardiovascular diseases, diabetes, and the increasing trend of self-monitoring are the key factors driving the global synthetic biosensors market during the forecast period. The major market players operating in the global biosensor market are focused on the production of cost-effective biosensor devices for accurate measurements. Additionally, the market players have huge growth opportunities due to the increasing applications of synthetic biosensors amid the global pandemic. Technological advancements in synthetic biosensors and developments in the field of nanotechnology are driving the expansion of the global synthetic biosensors market during the forecast period.
The main driving factors for the synthetic biosensor market include significant technological advancements in recent years, the emergence of nanotechnology-based synthetic biosensors, the rising usage of synthetic biosensors, the increase in the use of synthetic biosensors to monitor blood sugar levels in diabetic consumers, growing demand for home care devices during the COVID19 Pandemic, and increasing government initiatives towards diagnostics.
Report Coverage | Details |
Market Size in 2022 | USD 25.8 Billion |
Market Size by 2030 | USD 47.6 Billion |
Growth Rate from 2022 to 2030 | CAGR of 7.96% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered |
|
Regions Covered |
|
By type, the embedded device segment is a major revenue-generating segment in the synthetic biosensors market and is expected to dominate during the forecast period. These devices are widely used in a wide range of applications such as point of care, home diagnostics, food and beverage, research laboratories, environmental monitoring, and bioremediation. With the rise of the Internet of Things (IoT) devices, there has been a massive shift in connected healthcare applications. IoT enables real-time alerting, tracking, and monitoring, enabling convenient treatment, greater accuracy, appropriate physician intervention, and better holistic patient care. Many medical facilities have started to adopt integrated solutions for IoT-enabled medical devices to solve the shortage of doctors in remote areas.
Depending on the product, the market is divided into wearable and non-wearable. The wearable synthetic biosensors segment is predicted to show the highest growth rate during the forecast period. Wearable synthetic biosensors have attracted considerable attention due to their potential to change conventional medical diagnoses and concepts of continuous health monitoring. Wearable biosensor applications aim to transform centralized hospital care systems into personalized home medicine and reduce healthcare costs and diagnostic times. Today, wearable synthetic biosensors are bringing a wave of innovation to society. The availability of this real-time data enables better clinical decisions and translates into better health outcomes and more efficient use of the health system. Wearable synthetic biosensors can help detect health events early and avoid hospitalization. Such events are expected to accelerate the growth of the wearable biosensor market.
Depending on the application, the market is divided into food & beverages, POC, research lab, home diagnostics, environmental monitoring, and biodefense. The home diagnostics segment is predicted to show the highest growth rate during the forecast period. The growth of the market is attributed to the growing development of the healthcare industry, the high adoption rate of new diagnostic methods, and the convenience of using medical devices at home. As a result, manufacturers in the domestic diagnostic market are expanding their production capacity. In addition, with the growing demand in the wearables segment and as lifestyle-related diseases increase in prevalence, there is huge potential for the biosensor market in the home diagnostics segment.
Depending on the technology, the electrochemical synthetic biosensors accounted for the largest market share in the year 2021. Electrochemical synthetic biosensors are increasingly being used in non-medical applications, such as environmental monitoring; and also used in food and beverage quality inspection. Indirect monitoring via electrochemical synthetic biosensors can be performed for the analysis of organic pesticides or inorganic substances that interfere with the biocatalytic properties of the sensor.
North America is the dominating region in the synthetic biosensors market in the year 2021 owing to the growing prevalence of life-threatening diseases. The development and advancement of technology in the medical diagnostic industry is a key factors driving the biosensor market in North America. The presence of medical institutes and pharmaceutical research and development organizations in North America is driving market growth in the region. The growing awareness of health problems, environmental hazards, and food toxicity in North America has driven demand for synthetic biosensors in the region. Technological developments and advancements in diagnostic devices in North America are driving the synthetic biosensors market.
Asia-Pacific is expected to be the largest synthetic biosensors market during the forecast period. The presence of a large population base and the increasing prevalence of lifestyle-related diseases are the key factors driving the market growth in the Asia-Pacific region. In 2019, new materials for vaccine production and medical facilities were added to the 2019 national incentive list. Asian countries like China are now encouraging investment in the health sector and creating infrastructure, opportunities for foreign investors to access preferential policies and tax rates. These policies are expected to attract several opportunities for the synthetic biosensor market in this region.
Segments Covered in the Report
By Type
By Product
By Technology
By Application
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Synthetic Biosensors Market
5.1. COVID-19 Landscape: Synthetic Biosensors Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Synthetic Biosensors Market, By Type
8.1. Synthetic Biosensors Market, by Type, 2022-2030
8.1.1. Sensor Patch
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Embedded Device
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Synthetic Biosensors Market, By Product
9.1. Synthetic Biosensors Market, by Product, 2022-2030
9.1.1. Wearable Synthetic biosensors
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Non-wearable Synthetic biosensors
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Synthetic Biosensors Market, By Technology
10.1. Synthetic Biosensors Market, by Technology, 2022-2030
10.1.1. Electrochemical Synthetic biosensors
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Optical Synthetic biosensors
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Piezoelectric Synthetic biosensors
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Thermal Synthetic biosensors
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Nanomechanical Synthetic biosensors
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Synthetic Biosensors Market, By Application
11.1. Synthetic Biosensors Market, by Application, 2022-2030
11.1.1. POC
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Home Diagnostics
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Research Labs
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Environmental Monitoring
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Food & Beverages
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Biodefense
11.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Synthetic Biosensors Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Product (2017-2030)
12.1.3. Market Revenue and Forecast, by Technology (2017-2030)
12.1.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Product (2017-2030)
12.2.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Product (2017-2030)
12.3.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Product (2017-2030)
12.4.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Product (2017-2030)
12.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
Chapter 13. Company Profiles
13.1. Abbott
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Roche
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Medtronic
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Bio-Rad Laboratories, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. DuPont
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Biosensors International Group, Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Cytiva
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dexcom, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Lifescan IP Holdings, LLC
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Masimo
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client